Volume 18, Number 3—March 2012
CME ACTIVITY
Community-associated Clostridium difficile Infections, Monroe County, New York, USA
Ghinwa Dumyati
, Vanessa Stevens, George E. Hannett, Angela D. Thompson, Cherie Long, Duncan MacCannell, and Brandi Limbago
, Vanessa Stevens, George E. Hannett, Angela D. Thompson, Cherie Long, Duncan MacCannell, and Brandi LimbagoTable 3
Possible exposures to medications and health care during 12 weeks before diagnosis of CA-CDI in 42 patients, Monroe County, New York, USA, March 1–August 31, 2008*
| Exposure | No. (%) |
|---|---|
| Medication† | |
| Antimicrobial drugs | 32 (76) |
| Penicillins | 12 (31) |
| Clindamycin | 7 (18) |
| Cephalosporins | 5 (13) |
| Quinolones | 5 (13) |
| Macrolides | 4 (10) |
| Sulfa | 3 (8) |
| Metronidazole | 2 (5) |
| H2 blockers | 1 (2) |
| PPI | 11 (26) |
| Health care† | |
| None | 5 (12) |
| Outpatient visit | 35 (83) |
| Physician office | 29 (69) |
| Dentist | 13 (31) |
| Emergency department visit | 6 (14) |
| Visited a hospital or LTCF | 9 (21) |
| Health care–related job | 2 (5) |
*CA-CDI, community-associated Clostridium difficile infection; PPI, proton pump inhibitor; LTCF, long-term care facility.
†Multiple exposures could be reported in the 12 weeks before CDI.
